| 摘要 |
The invention relates to the use of at least one of the following Formula (I) compounds: wherein n=1, Ra notably represents -COOH, Rb notably represents -CH3-, Z notably represents -CH2-CHOH-, wherein the compound may be in the form of salts or, if at least one asymmetric carbon atom is present, in the form of isolated isomers or as a racemic mixture, as a physiological marker for carrying out a method for the in vitro or ex vivo diagnosis of psychiatric disorders and/or intestinal dysbioses.
|
